Alphatec Spine to Showcase Comprehensive Product Portfolio at the Upcoming 28th Annual North American Spine Society (NASS) Meeting in New Orleans, Louisiana

        Print
| Source: Alphatec Holdings, Inc.

CARLSBAD, Calif., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it will showcase several new products at the upcoming North American Spine Society (NASS) meeting in New Orleans, LA, which will be held from October 9th – 12th, 2013. Alphatec Spine will be located in booth number 631.

This year's product showcase will include:

ILLICO® Multi-Level (ML) Minimally Invasive Surgery System (MIS) is Alphatec Spine's simple, secure and highly versatile solution for minimally invasive posterior fixation for addressing instability in the thoracic and lumbar spine. With the ILLICO ML system surgeons are able to address complex multi-level spinal trauma and deformities and therefore ensure reliable reproducible results, which are designed to minimize pain and help speed recovery for their patients. This system features the minimally invasive ILLICO MIS Posterior Fixation System and the ILLICO FS Facet Fixation screws.

Alphatec NEXoss™ Nanostructure BA Matrix is a next-generation synthetic bone graft that provides the optimal microenvironment to support reliable, consistent bone growth for patients during the healing process. Alphatec NEXoss is comprised of an innovative bioactive scaffold engineered to support successful posterolateral fusions through two unique patented technologies that work in tandem: a unique collagen biopolymer that contributes to bone growth and nanostructure hydroxyapatite (HA) crystals that mimic natural bone composition, structure and size.

Pegasus™ Anchored Cervical Interbody System is the Company's newest anchored, cervical interbody device that provides surgeons with a simplified approach to ACDF procedures. Pegasus provides the delivery of a spacer with an integrated anchoring mechanism in a single-step, non-impaction implantation, which is designed to reduce operative time. The controlled anchor deployment provides surgeons confidence and simple intra-operative and post-operative removal if needed.

Alphatec Solus™ Anterior Lumbar Interbody Fusion Device is the latest innovative solution designed to provide fast, easy and effective stabilization for ALIF procedures using a single-step process thereby benefitting both surgeons and patients. Alphatec Solus delivers four points of fixation that are deployed simultaneously while providing substantial space to insert bone graft to help promote rapid fusion at the site, all of which are designed to increase fixation and decrease operative time.

"With our focus on physician-inspired solutions we are very excited to be able to join researchers, key thought leaders, and physicians at the 28th annual NASS meeting this month to discuss innovations in the field of spinal disorders and related conditions that can help lead to promising new therapeutic options for patients," said Les Cross, Chairman and CEO of Alphatec Spine. "We look forward to demonstrating the unique value and benefits of our broad portfolio of complementary products that help play a role in enabling patients to regain their active lifestyles and live better lives."

In addition, on Thursday, October 10th at 5:30 pm, Alphatec Spine is hosting an educational symposium featuring renowned thought leaders Dr. Antonio Castellvi, M.D., Dr. Boyle Cheng, PhD. and Dr. Celeste Abjornson, PhD. These distinguished professionals will be speaking about key topics in the prevention and treatment of spinal injuries and related conditions, including minimally invasive techniques for multi-level constructs with ILLICO, results of a biomechanical study of the NOVEL® ALIF device with integrated fixation and next-generation bone grafting solutions. The Company will also offer interactive sawbones workshops at its booth during exhibit hours.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets physician-inspired products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors.

Additional information can be found at www.alphatecspine.com.

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include references to the Company's belief that certain of its products offer competitive functionalities in the marketplace. In addition, forward-looking statements include the Company's ability to develop and commercialize new products, including the products discussed in this press release. The words "believe," "will," "should," "expect," "intend," "estimate" and "anticipate," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to; the uncertainty of success in developing or acquiring and commercializing new products or product technologies; acceptance of Alphatec Spine's products by the surgeon community, including the products discussed in this press release; Alphatec Spine's ability to develop and expand its U.S. and/or global revenues; continuation of favorable third part payor reimbursement for procedures performed using Alphatec Spine's products, including the products discussed in this press release; unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine's ability to successfully control its costs or achieve profitability; uncertainty of additional funding; Alphatec Spine's ability to compete with other competing products and with emerging new technologies; product liability exposure; patent infringement claims and claims related to Alphatec Spine's intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

Investor/Media Contact:

Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610